Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Aug;52(2):177–182. doi: 10.1038/bjc.1985.175

Detection of Ca antigen in sera from normal individuals and patients with benign and malignant breast disease.

A B Goodall, C J Evans, D Trivedi, R C Coombes, S M Chantler
PMCID: PMC1977115  PMID: 2411281

Abstract

Two assay procedures, an inhibition radioimmunoassay (Inhibition-RIA) and an immunoradiometric assay (IRMA), were established for the detection of circulating tumour-associated Ca antigen. There was a good correlation between results (r = 0.987) but the Inhibition-RIA was selected for extended tests on human sera from patients with breast disease because of its greater ease and economy in use. Circulating Ca antigen was not exclusive to malignancy and the level failed to discriminate between patients with primary carcinoma and those with benign disease. Ca antigen was present in sera of 100 healthy individuals (median 7.1 micrograms ml-1, range 1.8-24.4 micrograms ml)-1, 39 patients with benign disease (median 9.9 micrograms ml-1, range 2.5- greater than 100 micrograms ml-1) and in 67 patients with primary carcinoma (median 11.0 micrograms ml-1, range 3.8- greater than 100 micrograms ml-1). Elevated Ca antigen levels were found in 50% of patients with metastatic spread (median 30.7 micrograms ml-1, range 8.2- greater than 100 micrograms ml-1) and in some patients with primary disease but further studies are needed to determine the prognostic significance. Immunochemical studies confirmed that Ca antigen is a normal serum product but its function is unclear.

Full text

PDF
177

Images in this article

181Figure 4
on p.181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beckford U., Barbatis C., Beesley J. E., Linsell J. C., Chantler S. M. Localisation of Ca and HMFG2 antigens in breast tissue by immunoperoxidase, immunofluorescence, and immunoelectron microscopy. J Clin Pathol. 1985 May;38(5):512–520. doi: 10.1136/jcp.38.5.512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bramwell M. E., Bhavanandan V. P., Wiseman G., Harris H. Structure and function of the Ca antigen. Br J Cancer. 1983 Aug;48(2):177–183. doi: 10.1038/bjc.1983.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ceriani R. L., Sasaki M., Sussman H., Wara W. M., Blank E. W. Circulating human mammary epithelial antigens in breast cancer. Proc Natl Acad Sci U S A. 1982 Sep;79(17):5420–5424. doi: 10.1073/pnas.79.17.5420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coombes R. C., Dearnaley D. P., Ellison M. L., Neville A. M. Markers in breast and lung cancer. Ann Clin Biochem. 1982 Jul;19(Pt 4):263–268. doi: 10.1177/000456328201900415. [DOI] [PubMed] [Google Scholar]
  5. Foster C. S., Edwards P. A., Dinsdale E. A., Neville A. M. Monoclonal antibodies to the human mammary gland. I. Distribution of determinants in non-neoplastic mammary and extra mammary tissues. Virchows Arch A Pathol Anat Histol. 1982;394(3):279–293. doi: 10.1007/BF00430671. [DOI] [PubMed] [Google Scholar]
  6. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  7. McGee J. O., Woods J. C., Ashall F., Bramwell M. E., Harris H. A new marker for human cancer cells, 2 immunohistochemical detection of the Ca antigen in human tissues with the Ca1 antibody. Lancet. 1982 Jul 3;2(8288):7–10. doi: 10.1016/s0140-6736(82)91151-5. [DOI] [PubMed] [Google Scholar]
  8. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Waalkes T. P., Enterline J. P., Shaper J. H., Abeloff M. D., Ettinger D. S. Biological markers for breast carcinoma. Cancer. 1984 Feb 1;53(3 Suppl):644–651. doi: 10.1002/1097-0142(19840201)53:3+<644::aid-cncr2820531309>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  10. Wang D. Y., Knyba R. E., Bulbrook R. D., Millis R. R., Hayward J. L. Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer. Eur J Cancer Clin Oncol. 1984 Jan;20(1):25–31. doi: 10.1016/0277-5379(84)90030-0. [DOI] [PubMed] [Google Scholar]
  11. Woods J. C., Spriggs A. I., Harris H., McGee J. O. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody. Lancet. 1982 Sep 4;2(8297):512–514. doi: 10.1016/s0140-6736(82)90598-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES